GSK Consumer, GSK Pharma To Mix OTCs With Prescription Drugs
This article was originally published in PharmAsia News
GlaxoSmithKline Consumer Healthcare and parent GlaxoSmithKline PLC have formed a cross-functional strategy that their India units see as drawing on the strengths of each to help the other at its own specialty.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.